Literature DB >> 34859453

T cell activation niches-Optimizing T cell effector function in inflamed and infected tissues.

Noor Bala1, Alexander I McGurk1, Tiago Zilch1, Anastasia N Rup1, Evan M Carter1, Scott A Leddon1, Deborah J Fowell1.   

Abstract

Successful immunity to infection, malignancy, and tissue damage requires the coordinated recruitment of numerous immune cell subsets to target tissues. Once within the target tissue, effector T cells rely on local chemotactic cues and structural cues from the tissue matrix to navigate the tissue, interact with antigen-presenting cells, and release effector cytokines. This highly dynamic process has been "caught on camera" in situ by intravital multiphoton imaging. Initial studies revealed a surprising randomness to the pattern of T cell migration through inflamed tissues, behavior thought to facilitate chance encounters with rare antigen-bearing cells. Subsequent tissue-wide visualization has uncovered a high degree of spatial preference when it comes to T cell activation. Here, we discuss the basic tenants of a successful effector T cell activation niche, taking cues from the dynamics of Tfh positioning in the lymph node germinal center. In peripheral tissues, steady-state microanatomical organization may direct the location of "pop-up" de novo activation niches, often observed as perivascular clusters, that support early effector T cell activation. These perivascular activation niches appear to be regulated by site-specific chemokines that coordinate the recruitment of dendritic cells and other innate cells for local T cell activation, survival, and optimized effector function.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; cell trafficking; chemokines; cytokines; infectious disease; inflammation

Mesh:

Substances:

Year:  2021        PMID: 34859453      PMCID: PMC9218983          DOI: 10.1111/imr.13047

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   10.983


  151 in total

1.  Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells.

Authors:  Tobias Junt; E Ashley Moseman; Matteo Iannacone; Steffen Massberg; Philipp A Lang; Marianne Boes; Katja Fink; Sarah E Henrickson; Dmitry M Shayakhmetov; Nelson C Di Paolo; Nico van Rooijen; Thorsten R Mempel; Sean P Whelan; Ulrich H von Andrian
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

2.  The Chemoattractant Receptor Ebi2 Drives Intranodal Naive CD4+ T Cell Peripheralization to Promote Effective Adaptive Immunity.

Authors:  Antonio P Baptista; Anita Gola; Yuefeng Huang; Pedro Milanez-Almeida; Parizad Torabi-Parizi; Joseph F Urban; Virginia S Shapiro; Michael Y Gerner; Ronald N Germain
Journal:  Immunity       Date:  2019-04-30       Impact factor: 31.745

Review 3.  T follicular helper cells in space-time.

Authors:  Hai Qi
Journal:  Nat Rev Immunol       Date:  2016-08-30       Impact factor: 53.106

4.  Dynamic signaling by T follicular helper cells during germinal center B cell selection.

Authors:  Ziv Shulman; Alexander D Gitlin; Jason S Weinstein; Begoña Lainez; Enric Esplugues; Richard A Flavell; Joseph E Craft; Michel C Nussenzweig
Journal:  Science       Date:  2014-08-29       Impact factor: 47.728

Review 5.  G-protein coupled receptors and ligands that organize humoral immune responses.

Authors:  Erick Lu; Jason G Cyster
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

6.  Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration.

Authors:  Makoto Kurachi; Junko Kurachi; Fumiko Suenaga; Tatsuya Tsukui; Jun Abe; Satoshi Ueha; Michio Tomura; Kei Sugihara; Shiki Takamura; Kazuhiro Kakimi; Kouji Matsushima
Journal:  J Exp Med       Date:  2011-07-25       Impact factor: 14.307

7.  Microglia and Perivascular Macrophages Act as Antigen Presenting Cells to Promote CD8 T Cell Infiltration of the Brain.

Authors:  Emma N Goddery; Cori E Fain; Chloe G Lipovsky; Katayoun Ayasoufi; Lila T Yokanovich; Courtney S Malo; Roman H Khadka; Zachariah P Tritz; Fang Jin; Michael J Hansen; Aaron J Johnson
Journal:  Front Immunol       Date:  2021-08-30       Impact factor: 8.786

8.  Three phases of CD8 T cell response in the lung following H1N1 influenza infection and sphingosine 1 phosphate agonist therapy.

Authors:  Melanie P Matheu; John R Teijaro; Kevin B Walsh; Milton L Greenberg; David Marsolais; Ian Parker; Hugh Rosen; Michael B A Oldstone; Michael D Cahalan
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

9.  CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.

Authors:  Mauro Di Pilato; Raphael Kfuri-Rubens; Jasper N Pruessmann; Aleksandra J Ozga; Marius Messemaker; Bruno L Cadilha; Ramya Sivakumar; Chiara Cianciaruso; Ross D Warner; Francesco Marangoni; Esteban Carrizosa; Stefanie Lesch; James Billingsley; Daniel Perez-Ramos; Fidel Zavala; Esther Rheinbay; Andrew D Luster; Michael Y Gerner; Sebastian Kobold; Mikael J Pittet; Thorsten R Mempel
Journal:  Cell       Date:  2021-08-02       Impact factor: 66.850

Review 10.  T Follicular Helper Cells As a New Target for Immunosuppressive Therapies.

Authors:  Lin Yan; Kitty de Leur; Rudi W Hendriks; Luc J W van der Laan; Yunying Shi; Lanlan Wang; Carla C Baan
Journal:  Front Immunol       Date:  2017-11-07       Impact factor: 7.561

View more
  2 in total

1.  T-ISAAC: a novel TCR cloning system derived from T cells' cis activation.

Authors:  Zehua Tian
Journal:  Signal Transduct Target Ther       Date:  2022-07-06

2.  Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity.

Authors:  Ssu-Hsueh Tseng; Max A Cheng; Emily Farmer; Louise Ferrall; Yu Jui Kung; Brandon Lam; Ling Lim; T-C Wu; Chien-Fu Hung
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 12.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.